ARGS
Argos Therapeutics, Inc.
ARGS
ARGS
Delisted
ARGS was delisted on the 24th of April, 2018.
43 hedge funds and large institutions have $7.55M invested in Argos Therapeutics, Inc. in 2017 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 16 increasing their positions, 12 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
33% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 12
93% less capital invested
Capital invested by funds: $102M → $7.55M (-$94.5M)
Holders
43
Holding in Top 10
1
Calls
$2.44M
Puts
$41K
Top Buyers
| 1 | +$360K | |
| 2 | +$99K | |
| 3 | +$57K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$48.9K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$29.2K |
Top Sellers
| 1 | -$1.39M | |
| 2 | -$845K | |
| 3 | -$701K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$595K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$440K |